Your session is about to expire
← Back to Search
BFR deflate for Anterior Cruciate Ligament Reconstruction Rehabilitation
Study Summary
This trial is testing whether or not deflating the blood flow restrictive (BFR) cuff between exercises results in greater quadriceps strength and functional outcomes after MPFL or ACL reconstruction, as well as reduced pain and improved exercise tolerance.
- Medial Patellofemoral Ligament Reconstruction Rehabilitation
- Anterior Cruciate Ligament Reconstruction Rehabilitation
Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- You have any medical device implanted in your body.You have a history of blood clots in deep veins, vascular graft, varicose veins, or sickle cell anemia.You have a current lower leg condition, other than MPFL or ACL reconstruction, that could affect how you walk.You are unable to fully understand and agree to participate in the study.You have diabetes or high blood pressure that is not being managed well.You recently had swelling, bleeding or infection in your legs.You had surgery to reconstruct the ligament in your knee called the medial patellar femoral ligament or anterior cruciate ligament.
- Group 1: BFR deflate
- Group 2: BFR do not deflate
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Are there any participation openings in this research currently available?
"Affirmative. Clinicaltrials.gov records the status of this clinical trial as open, with an initial post date on June 29th 2021 and recent update dated June 16th 2022. The study is in need of 32 participants at one site specifically."
How many participants have joined this trial thus far?
"Indeed, current details on clinicaltrials.gov demonstrate that this study is actively searching for participants. It was initially posted to the site on June 29th 2021 and updated most recently in mid-June of 2022. 32 patients need to be enrolled from one location."
Is there an age limit on joining this particular experiment?
"The requirements for enrolment into this experiment indicate that individuals aged between 13 and 40 are eligible to participate."
To what extent is enrollment in this trial open to the public?
"For this trial, 32 individuals aged 13 to 40 with current medial patellar femoral ligament reconstruction rehab are being sought out. Furthermore, these participants must meet requirements for post-operative Medial Patellar Femoral Ligament or Anterior Cruciate Ligament Reconstruction."
Share this study with friends
Copy Link
Messenger